Injective CEO meets White House, SEC and CFTC officials on onchain finance

Injective CEO Eric Chen recently met with officials from the White House, the SEC, and the CFTC. The agenda was advancing regulated onchain finance in the United States. The meetings took place in October 2026, with Chen joined by other Injective leadership. The company has not disclosed specific outcomes. What Injective brought to the table The discussions centered on two linked themes. The first was regulated onchain finance. The second was the tokenization of real-world assets, known in the industry as RWAs. Injective arrived with a credential most crypto projects lack. In August 2026, the SEC registered it as a transfer agent. Transfer agents are the unglamorous record-keepers of traditional finance. They maintain the official books showing who owns which securities. With that status, Injective can keep those ownership records for tokenized securities, and that is the plumbing institutional players need before they move real money onchain. The company also pointed to activity on its own network. Injective reports over $1 billion in tokenized RWA value onchain. It says cumulative RWA perpetual volume has passed $5.3 billion, spread across asset classes that include equities and ...